![C. Everett Koop](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
C. Everett Koop
Plus aucun poste en cours
Historique de carrière de C. Everett Koop
Anciens postes connus de C. Everett Koop
Sociétés | Poste | Début | Fin |
---|---|---|---|
Biopure Corp.
![]() Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/12/1990 | - |
Formation de C. Everett Koop
Cornell University | Doctorate Degree |
Dartmouth College | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Doctorate Degree | 2 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Biopure Corp.
![]() Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- C. Everett Koop
- Expérience